This Notice of Funding Opportunity (NOFO) supports Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. It aims to foster robust collaborative partnerships between U.S. and South African investigators. Research areas include HIV/AIDS, co-morbidities, co-infections, associated implementation science, and data science. The program’s core objective is to advance scientific discoveries, facilitate the sharing of technologies and approaches, and address local public health needs. Ultimately, this initiative contributes significantly to global HIV/AIDS research efforts through international cooperation and shared expertise, building on prior phases of the program to tackle pressing health challenges. The collaboration ensures research addresses critical global health priorities.
Opportunity ID: 356439
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-24-023 |
| Funding Opportunity Title: | U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 17, 2024 |
| Last Updated Date: | Sep 17, 2024 |
| Original Closing Date for Applications: | Mar 12, 2025 |
| Current Closing Date for Applications: | Mar 12, 2025 |
| Archive Date: | Apr 17, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); See funding opportunity for eligibility criteria. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support research projects under Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. Research areas supported under this program include HIV/AIDS, HIV/AIDS co-morbidities and co-infections, HIV/AIDS-associated implementation science, and HIV/AIDS-associated data science. The hallmark of the U.S.-South Africa program is the development of collaborative partnerships between South African investigators and United States (U.S.) investigators. Through international collaboration, this research will advance scientific discoveries, promote sharing of technologies and approaches, and serve local public health needs and priorities in support of global HIV/AIDS research. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-023.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288374 | Feb 12, 2025 | Mar 12, 2025 | View |
Package 1
Mandatory forms
356439 RR_SF424_5_0-5.0.pdf
356439 PHS398_CoverPageSupplement_5_0-5.0.pdf
356439 RR_OtherProjectInfo_1_4-1.4.pdf
356439 PerformanceSite_4_0-4.0.pdf
356439 RR_KeyPersonExpanded_4_0-4.0.pdf
356439 PHS398_ResearchPlan_5_0-5.0.pdf
356439 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356439 RR_Budget_3_0-3.0.pdf
356439 RR_SubawardBudget30_3_0-3.0.pdf
356439 PHS398_ModularBudget_1_2-1.2.pdf
356439 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
